Related Experiment Video

Updated: Oct 3, 2025

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

514

MicroRNAs: Emerging Regulators of Metastatic Bone Disease in Breast Cancer

Marie-Therese Haider1, Daniel J Smit2, Hanna Taipaleenmäki1,3,4

  • 1Molecular Skeletal Biology Laboratory, Department of Trauma and Orthopedic Surgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Cancers
|February 15, 2022
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in breast cancer bone metastasis. These small RNA molecules influence tumor growth and bone destruction, offering potential as diagnostic biomarkers and therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Bone metastasis is a common complication of advanced breast cancer, leading to significant bone destruction.
  • Cancer cells disrupt the bone microenvironment through cell-cell contacts and secreted molecules, including RNA.
  • MicroRNAs (miRNAs) are short non-coding RNAs that regulate gene expression post-transcriptionally.

Purpose of the Study:

  • To review the role of miRNAs in breast cancer bone metastasis.
  • To discuss the impact of miRNAs on the bone microenvironment.
  • To explore the diagnostic and therapeutic potential of miRNAs in metastatic bone disease.

Main Methods:

  • Literature review of pre-clinical and clinical studies.
  • Analysis of miRNA functions in breast cancer and bone metastasis.
  • Evaluation of miRNA roles in cellular interactions within the bone marrow.

Main Results:

  • miRNAs are critical regulators of physiological and pathological processes, including breast cancer progression.
  • miRNAs can promote or inhibit tumor growth and bone destruction depending on their targets.
  • miRNAs show potential as diagnostic and prognostic biomarkers for metastatic bone disease.

Conclusions:

  • miRNAs play a significant role in the pathogenesis of breast cancer bone metastasis.
  • miRNAs represent promising biomarkers for diagnosis and prognosis.
  • miRNAs are being investigated as novel therapeutic targets for metastatic bone disease.
Keywords:
bone metastasisbone microenvironmentbreast cancermicroRNAtargeted therapy

More Related Videos

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis07:00

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis

Published on: September 26, 2016

16.8K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

6.9K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.4K